Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Twist Bioscience Corporation (TWST) Misses Q3 EPS by 7c
August 6, 2021 7:38 AM EDTTwist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($0.82), $0.07 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $35 million versus the consensus estimate of $32.27 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2021 revenue of $129-132 million, versus the... More
